SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001140361-24-040313
Filing Date
2024-09-06
Accepted
2024-09-06 08:15:45
Documents
2
Group Members
PING LAN

Document Format Files

Seq Description Document Type Size
1 SC 13D ef20035610_sc13d.htm SC 13D 82705
2 EXHIBIT 1 ef20035610_ex99-1.htm EX-99.1 4798
  Complete submission text file 0001140361-24-040313.txt   89078
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82442 | Film No.: 241282994
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address NIHONBASHI-HONCHO YS BLDG 3F 2-2-2 NIHONBASHI-HONCHO, CHUO-KU TOKYO M0 103-0023
Business Address
Luo Ying (Filed by) CIK: 0001959160 (see all company filings)

Type: SC 13D